+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Respiratory Disease Vaccine Market by Infection (Influenza Virus, Pertussis, Streptococcus Pneumoniae), Type (Bacterial Vaccine, Combination Vaccine, Viral Vaccine), Age Group - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5012997
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Respiratory Disease Vaccine Market size was estimated at USD 23.42 billion in 2023, USD 24.78 billion in 2024, and is expected to grow at a CAGR of 5.87% to reach USD 34.93 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Disease Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Disease Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Disease Vaccine Market, highlighting leading vendors and their innovative profiles. These include Astrazeneca PLC, Bavarian Nordic A/S, Bharat Biotech International Ltd., CanSino Biologics Inc., Emergent BioSolutions, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Sanofi S.A., Seqirus USA Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., and Vaxine Pty Ltd.

Market Segmentation & Coverage

This research report categorizes the Respiratory Disease Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Infection
    • Influenza Virus
    • Pertussis
    • Streptococcus Pneumoniae
    • Tuberculosis
  • Type
    • Bacterial Vaccine
    • Combination Vaccine
    • Viral Vaccine
  • Age Group
    • Adolescent Vaccination
    • Adult Vaccination
    • Infant Vaccination
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Respiratory Disease Vaccine Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Disease Vaccine Market?
  3. What are the technology trends and regulatory frameworks in the Respiratory Disease Vaccine Market?
  4. What is the market share of the leading vendors in the Respiratory Disease Vaccine Market?
  5. Which modes and strategic moves are suitable for entering the Respiratory Disease Vaccine Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Respiratory Disease Vaccine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of respiratory disorders
5.1.1.2. Clinical trials and vaccines developments in pipeline
5.1.1.3. Government initiatives supporting respiratory health
5.1.2. Restraints
5.1.2.1. Lack of inadequate delivery infrastructure & limited awareness
5.1.3. Opportunities
5.1.3.1. Increasing R&D expenditure by leading companies
5.1.3.2. Increase vaccine availability through reselling collaborations
5.1.4. Challenges
5.1.4.1. Consumer trust & confidence in respiratory disease vaccination
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Respiratory Disease Vaccine Market, by Infection
6.1. Introduction
6.2. Influenza Virus
6.3. Pertussis
6.4. Streptococcus Pneumoniae
6.5. Tuberculosis
7. Respiratory Disease Vaccine Market, by Type
7.1. Introduction
7.2. Bacterial Vaccine
7.3. Combination Vaccine
7.4. Viral Vaccine
8. Respiratory Disease Vaccine Market, by Age Group
8.1. Introduction
8.2. Adolescent Vaccination
8.3. Adult Vaccination
8.4. Infant Vaccination
9. Americas Respiratory Disease Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Respiratory Disease Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Respiratory Disease Vaccine Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Astrazeneca PLC
13.1.2. Bavarian Nordic A/S
13.1.3. Bharat Biotech International Ltd.
13.1.4. CanSino Biologics Inc.
13.1.5. Emergent BioSolutions, Inc.
13.1.6. GlaxoSmithKline PLC
13.1.7. Johnson & Johnson Services, Inc.
13.1.8. Merck & Co., Inc.
13.1.9. Moderna, Inc.
13.1.10. Pfizer Inc.
13.1.11. Sanofi S.A.
13.1.12. Seqirus USA Inc.
13.1.13. Serum Institute of India Pvt. Ltd.
13.1.14. Sinovac Biotech Ltd.
13.1.15. Vaxine Pty Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. RESPIRATORY DISEASE VACCINE MARKET RESEARCH PROCESS
FIGURE 2. RESPIRATORY DISEASE VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESPIRATORY DISEASE VACCINE MARKET DYNAMICS
FIGURE 7. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2023 VS 2030 (%)
FIGURE 8. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 12. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. RESPIRATORY DISEASE VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. RESPIRATORY DISEASE VACCINE MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. RESPIRATORY DISEASE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RESPIRATORY DISEASE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 6. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFLUENZA VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY PERTUSSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STREPTOCOCCUS PNEUMONIAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY BACTERIAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COMBINATION VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY VIRAL VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 15. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADOLESCENT VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY ADULT VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFANT VACCINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 28. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 29. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 31. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 45. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 46. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 48. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 49. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 101. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 109. NORWAY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. POLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 113. POLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 116. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 127. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY INFECTION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM RESPIRATORY DISEASE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. RESPIRATORY DISEASE VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. RESPIRATORY DISEASE VACCINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. RESPIRATORY DISEASE VACCINE MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astrazeneca PLC
  • Bavarian Nordic A/S
  • Bharat Biotech International Ltd.
  • CanSino Biologics Inc.
  • Emergent BioSolutions, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Seqirus USA Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd.
  • Vaxine Pty Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 24.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.93 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal

Related Topics

Related Reports

Respiratory Disease Vaccine Global Market Report 2024 - Product Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 181 Pages
  • Global
From
Pertussis Vaccine Global Market Report 2024 - Product Image

Pertussis Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 - Product Image

Bordetella pertussis (Whooping Cough) Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

  • Report
  • Global
From
2024 Global Forecast for Pertussis Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Pertussis Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From

About the Respiratory Disease Vaccine Market

The Respiratory Disease Vaccine market is a subset of the larger Respiratory Drugs market. Vaccines are used to prevent the spread of respiratory diseases, such as influenza, pneumonia, and tuberculosis. Vaccines are typically administered to children and adults, and are often recommended for those at high risk of developing respiratory diseases. Vaccines are typically administered through injection, nasal spray, or oral drops. The Respiratory Disease Vaccine market is highly competitive, with many companies offering a variety of vaccines. Companies in the market include Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. These companies are involved in the research, development, and production of vaccines for a variety of respiratory diseases. Additionally, many of these companies are involved in the distribution of vaccines to healthcare providers and pharmacies. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.